Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 7:12:1815-1825.
doi: 10.2147/IJN.S127349. eCollection 2017.

Current applications and future prospects of nanomaterials in tumor therapy

Affiliations
Review

Current applications and future prospects of nanomaterials in tumor therapy

Yu Huang et al. Int J Nanomedicine. .

Abstract

Tumors are one of the most serious human diseases and cause numerous global deaths per year. In spite of many strategies applied in tumor therapy, such as radiation therapy, chemotherapy, surgery, and a combination of these treatments, tumors are still the foremost killer worldwide among human diseases, due to their specific limitations, such as multidrug resistance and side effects. Therefore, it is urgent and necessary to develop new strategies for tumor therapy. Recently, the fast development of nanoscience has paved the way for designing new strategies to treat tumors. Nanomaterials have shown great potential in tumor therapy, due to their unique properties, including passive targeting, hyperthermia effects, and tumor-specific inhibition. This review summarizes the recent progress using the innate antitumor properties of metallic and nonmetallic nanomaterials to treat tumors, and related challenges and prospects are discussed.

Keywords: nanomaterials; nanoparticles; nanotechnology; tumor.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Metallic and nonmetallic nanomaterials that act as active medicine or drug additive in tumor therapy through their innate antitumor properties. Abbreviations: NMs, nanomaterials; NPs, nanoparticles.
Figure 2
Figure 2
Transmission electron microscope images of (A) iron oxide nanoparticles; (B) gold nanoparticles; (C) gold nanocages; (D) cerium oxide nanoparticles. Notes: Figure A adapted with permission from Bronstein LM, Huang XL, Retrum J, et al. Influence of iron oleate complex structure on iron oxide nanoparticle formation. Chem Mater. 2007;19(15):3624–3632. Copyright © 2007, American Chemical Society. Figure B adapted with permission from Schulz-Dobrick M, Sarathy KV, Jansen M. Surfactant-free synthesis and functionalization of gold nanoparticles. J Am Chem Soc. 2005;127(37):12816–12817. Copyright © 2007, American Chemical Society. Figure C adapted with permission from Chen JY, Wang DL, Xi JF, et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett. 2007;7(5):1318–1322. Copyright © 2007, American Chemical Society. The method reported in Lee et al was used when creating the nanoparticles shown in Figure D.
Figure 3
Figure 3
Structures of nonmetallic nanomaterials for tumor therapy. Notes: (A) C60; (B) carbon nanotubes; (C) graphene; (D) chitosan-structure units β-(1,4)-2-amino-d-glucose and β-(1,4)-2-acetamido-d-glucose.

Similar articles

Cited by

References

    1. Steven A, Seliger B. Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target. Oncotarget. 2016;7(23):35454–35465. - PMC - PubMed
    1. Sarkar FH, Banerjee S, Li YW. Pancreatic cancer: pathogenesis, prevention and treatment. Toxicol Appl Pharm. 2007;224(3):326–336. - PMC - PubMed
    1. Tang HD, Qiao J, Fu YX. Immunotherapy and tumor microenvironment. Cancer Lett. 2016;370(1):85–90. - PMC - PubMed
    1. Li B, Li TW, Pignon JC, et al. Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat Genet. 2016;48(7):725–732. - PMC - PubMed
    1. Luo JF, Luo YX, Sun JH, Zhou YR, Zhang YJ, Yang X. Adeno-associated virus-mediated cancer gene therapy: current status. Cancer Lett. 2015;356(2):347–356. - PMC - PubMed

LinkOut - more resources